Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.33 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | TOP1 | P11387 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15527648 | 0.86 | CYP1A2 (0.37) | CYP3A4SOAT2SOAT1FAAHEPHX2 | |
| SCHEMBL15527382 | 0.81 | CYP3A4 (0.33) | CYP3A4TDP1MAOB | |
| SCHEMBL9861825 | 0.79 | CYP3A4 (0.32) | CYP3A4TDP1 | |
| SCHEMBL9861833 | 0.79 | CYP3A4 (0.32) | CYP3A4TDP1 | |
| SCHEMBL1652690 | 0.76 | CYP3A4 (0.36) | CYP3A4TDP1MAOB | |
| SCHEMBL15364455 | 0.76 | CYP3A4 (0.36) | CYP3A4TDP1MAOBESR1ESR2 | |
| SCHEMBL14819091 | 0.76 | CYP3A4 (0.36) | CYP3A4TDP1MAOB | |
| SCHEMBL1652688 | 0.76 | CYP3A4 (0.36) | CYP3A4TDP1MAOB | |
| SCHEMBL28750858 | 0.76 | CYP3A4 (0.36) | CYP3A4TDP1MAOB | |
| SCHEMBL14262345 | 0.76 | CYP3A4 (0.36) | CYP3A4TDP1MAOBESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2282986-B1 | METHOD FOR PRODUCING AROMATIC AND HETEROAROMATIC CARBOXYLIC ACIDS, CARBOXYLIC ACID ESTERS AND CARBOXYLIC ACID AMIDES | BASF SE (DE) | 2017-04-19 | — | — | EP | disclosed |
| US-8703992-B2 | Method for producing aromatic and heteroaromatic carboxylic acids, carboxylic acid esters and carboxylic acid amides | BASF SE (DE) | 2014-04-22 | — | — | US | disclosed |
| US-20110172456-A1 | Method for Producing Aromatic and Heteroaromatic Carboxylic Acids, Carboxylic Acid Esters and Carboxylic Acid Amides | BASF SE (DE) | 2011-07-14 | — | — | US | disclosed |
| EP-2282986-A1 | METHOD FOR PRODUCING AROMATIC AND HETEROAROMATIC CARBOXYLIC ACIDS, CARBOXYLIC ACID ESTERS AND CARBOXYLIC ACID AMIDES | BASF SE (DE) | 2011-02-16 | — | — | EP | disclosed |
| WO-2009144197-A1 | METHOD FOR PRODUCING AROMATIC AND HETEROAROMATIC CARBOXYLIC ACIDS, CARBOXYLIC ACID ESTERS AND CARBOXYLIC ACID AMIDES | BASF SE (DE) | 2009-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172456-A1 | Method for Producing Aromatic and Heteroaromatic Carboxylic Acids, Carboxylic Acid Esters and Carboxylic Acid Amides | CBR3, HRH3, HRH4 | CYP3A4 193/4885TDP1 2635/4885SOAT2 2028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.